Imaging in 2020
September 30 – October 4, 2001
Organizers: Thomas Meade, Daniel Sullivan, and James Tatum
SUNDAY
Ultrasonic Microscanning: Present Status and Future Prospects
Peter Wells, University of Bristol, UK
Truman Brown, Columbia University
TUESDAY
Chair: Truman Brown, Columbia University
Structural and Functional Contrast in Diffuse Optical Mammography
Bruce Tromberg, University of California, Irvine
Responsive MR Agents: Is Fast Water Exchange Necessary?
A. Dean Sherry, University of Texas at Dallas
Use of Quantum Dots in Cellular Imaging
Walt Mahoney, Quantum Dot Corporation
Immune Cell Trafficking in Autoimmunity and Neoplastic Disease
Chris Contag, Stanford University
Keynote Address
Mapping the Human Brain in 2020 – What Did We Learn 21 Years Ago?
John Mazziota, UCLA
THURSDAY
Chair: Tom Meade,California Institute of Technology
Lanthanide Chelates: Multipurpose Probes for Biomedical Imaging
Darryl Bornhop, Texas Tech University
Onward and Downward: Higher MRI Field Strength means Lower Detection Thresholds for Contrast Reagents
Charles Springer, Brookhaven National Laboratory
Group Discussion
MONDAY
Chair: Tom Budinger, University of California, Berkeley
Synergy between Imaging and High Throughput Tissue Analysis
King Chuen P. Li, Stanford University
Molecular Imaging with PET: A Technological Perspective
Simon Cherry, University of California, Davis
Optical Coherence Tomography for Structural and Functional Imaging
James Fujimoto, Massachusetts Institute of Technology
Targeting of Paramagnetic Complexes to Proteins and Cells for Novel Diagnostic Applications in MRI
Silvio Aime, University of Torino, Italy
PET and SPECT Strategies for Molecular Imaging
David Piwnica-Worms, Washington University, St. Louis
Imaging Signal Transduction with Genetically Encoded Indicators
Martin Pomper, Harvard University / MGH
WEDNESDAY
Chair: Juri Gelovani, Memorial Sloan-Kettering Cancer Center
Multimodal Imaging of Vertebrate Neural Development
Russ Jacobs, California Institute of Technology
Early Detection of Chemotherapy Response in Tumors using the MR-visible Apparent Diffusion Coefficient of Water
Robert Gillies, University of Arizona Cancer Center
MR Imaging with Intermolecular Multiple-Quantum Coherences
Warren Warren, Princeton University
Defining Molecular Targets for Treatment and Imaging
Ed Sausville, National Cancer Institute
NCI Discussion Session: NCI Challenge on Imaging Agent Development
NMR and NIR Molecular Imaging of Cancer
Jerry Glickson, University of Pennsylvania
Juri Gelovani, Memorial Sloan-Kettering Cancer Center